We first determined the effect of SIRT6 on NSCLC cell drug resistance by the CCK-8 method and found that overexpression of SIRT6 could induce the development of erlotinib resistance in cells (the IC50 values in PC9/vector vs. The gene discussed is SIRT6; the disease is non-small cell lung carcinoma.